0001140361-21-037038.txt : 20211108 0001140361-21-037038.hdr.sgml : 20211108 20211108183302 ACCESSION NUMBER: 0001140361-21-037038 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211104 FILED AS OF DATE: 20211108 DATE AS OF CHANGE: 20211108 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Zocca Mai-Britt CENTRAL INDEX KEY: 0001890736 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41008 FILM NUMBER: 211389286 MAIL ADDRESS: STREET 1: 1209 ORANGE STREET CITY: WILMINGTON STATE: DE ZIP: 19801 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IO Biotech, Inc. CENTRAL INDEX KEY: 0001865494 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 870909276 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: OLE MAALOES VEH 3 CITY: COPENHAGEN STATE: G7 ZIP: 2200 BUSINESS PHONE: 4570702980 MAIL ADDRESS: STREET 1: OLE MAALOES VEH 3 CITY: COPENHAGEN STATE: G7 ZIP: 2200 4 1 form4.xml FORM 4 X0306 4 2021-11-04 0001865494 IO Biotech, Inc. IOBT 0001890736 Zocca Mai-Britt C/O IO BIOTECH, INC. OLE MAALOES VEH 3 COPENHAGEN G7 2200 DENMARK true true Chief Executive Officer Stock Option (Right to Buy) 14 2021-11-04 4 A 0 414212 0 A 2031-11-04 Common Stock 414212 414212 D These options vest in 1/48 monthly increments of the vesting commencement date of November 4, 2021, subject to the reporting person's continued service through the applicable vesting date, and subject to 50% acceleration upon a change of control and subject to 100% acceleration upon termination of service by the Issuer without cause or by the reporting person within 24 months of a change of control. /s/ Brian Burkavage, Attorney-in-Fact for Mai-Britt Zocca 2021-11-08